491
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assessing the Pharmacist’s Role in Counseling Asthmatic Adults Using the Correct Inhaler Technique and Its Effect on Asthma Control, Adherence, and Quality of Life

ORCID Icon, ORCID Icon & ORCID Icon
Pages 961-972 | Received 29 Oct 2022, Accepted 28 Mar 2023, Published online: 06 Apr 2023

Figures & data

Figure 1 The study protocol explains the process of the study and data collected at baseline and follow-up.

Figure 1 The study protocol explains the process of the study and data collected at baseline and follow-up.

Figure 2 Inhaler technique education protocol.

Figure 2 Inhaler technique education protocol.

Table 1 Demographic Characteristics of the Study Sample (n = 157) for the Active (n = 79) and Control Groups (n = 78)

Figure 3 Study flow for the study sample (n = 157).

Figure 3 Study flow for the study sample (n = 157).

Table 2 Inhaler Technique Scores and Asthma Control Test (ACT) Scores Comparing Patients in the Active (n = 79) and Control Groups (n = 78) at Baseline and Active (n = 76) and Control (n = 75) at the Follow-Up

Figure 4 Active group (n = 79) inhaler technique score at baseline before training, baseline after training, and at follow-up (n = 76).

Figure 4 Active group (n = 79) inhaler technique score at baseline before training, baseline after training, and at follow-up (n = 76).

Figure 5 Inhaler technique scores for the control group (n = 78) at baseline before training, baseline after training, and at follow-up (n = 75).

Figure 5 Inhaler technique scores for the control group (n = 78) at baseline before training, baseline after training, and at follow-up (n = 75).

Table 3 Clinical Outputs for Adherence, Comparing Patients in the Active (n = 79) and Control Groups (n = 78) at Baseline, and Active (n = 76) and Control (n = 75) at the Follow-Up

Table 4 Clinical Outputs for AQLQ, Comparing Participants in the Active Group at the Baseline (n = 79) and Follow-Up (n = 76) at Baseline, and Control Group at the Baseline (n = 78) and at the Follow-Up (n = 75)